Enzymatica AB (publ), a life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract. The company’s product includes ColdZyme, a mouth spray to treat and alleviate cold and flu symptoms. It also provides enzyme formulations for skin care. The company offers its products through contract organizations and partner agreements with distributors who sell the products under the ViruProtect, STADAProtect, and Bisolviral brand names. Enzymatica AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Egstrand, Claus

Employees

Website

www.enzymatica.se

IPO Date

2011-06-14

Headquarters

Ideon Science Park, Scheelevägen 19, Lund, Skåne County, 223 70, Sweden

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Enzymatica ENZY

Enzymatica Earnings Call Summary

Enzymatica Earnings

Transcripts

Events

About Enzymatica AB (publ)

Enzymatica
ENZY